Safety and Efficacy of Port for CART Administration in Large B-cell Lymphoma

Key Points

• CAR-T therapy demonstrates safety and efficacy when administered through a port catheter in B-cell lymphoma patients.
• Patients reported fewer complications, with a notable decrease in infection rates to 5.2%.
• Observational analysis of treatment methods highlights the importance of safe administration routes for CAR-T therapy.
• These findings suggest that using a port may enable smoother delivery of CAR-T therapy in an oncology setting.